Archives for April 2020

April 2020 - Page 3 of 14 - Money Morning - Only the News You Can Profit From

Markets Live Recap: Stocks Begin the Week Strong as Economic Outlook Brightens

by

Stocks rose 1.6% today as investors felt optimistic about governments around the world reopening their economies amid the coronavirus outbreak.

In addition to some U.S. states, Italy, Germany, and France said they're also looking to ease the quarantine policies that have been in place for the last two months.

If economies can reopen and consumers feel confident, stocks could continue to rally.

But if the COVID-19 curve starts to steepen as a result, that would likely send stocks lower.

And we could break through the recent lows made last month.

Here's what our experts – Chris Johnson, Tom Gentile, D.R. Barton, Jr., and Shah Gilani – think investors should be doing with their portfolios this week.

Read more...

Tech Stocks 2020: 3 to Buy and 3 to Avoid

by

With the coronavirus crash taking 23% off the Dow Jones Industrial Average to date, more folks are catching the "buy the dip" wave.

Buying the dip, even if it's yet to bottom out, is a great way to "average down," as Shah Guilani, Money Morning's capital wave strategist, puts it.

According to Shah, long-term wealth is built from raising the long-term average profit accumulated over time.

It's simple: buying Alphabet Inc. (NASDAQ: GOOG) for $1,260 right now is better than buying it at $1,367 on Jan. 1.

Read more...

Two Penny Stocks to Buy as Market Conditions Improve

by

Investors are looking for the next big opportunity as markets rebound from the ongoing COVID-19 outbreak.

And our top penny stocks to buy today are the perfect entry point.

With evidence that more Americans have developed antibodies than previously thought and questions about the models tied to the virus, we are seeing momentum slowly returning to the market.

Read more...

How to Buy Red-Hot Zoom Stock - at Your Price

by

Of all the questions we get here at Money Morning, one we see the most is: "Is it too late to buy Zoom?"

Of course, these folks are talking about Zoom Video Communications Inc. – the videoconferencing player that's seeing torrid growth because of the COVID-19 pandemic.

Just last week, Zoom CEO Eric Yuan revealed that 300 million folks are using the company's software – a jump of 100 million, or 50%, from just last month. In December, the company's user base was a "mere" 10 million.

And Zoom's shares have, well, zoomed. From their trading price of roughly a year ago, the shares have rocketed to $170 – a jump of 160% during that stretch.

Huge moves like this are based, in part, on the numbers. But they're also fueled by a hefty slug of emotion, which can make buying, selling, and trading pretty tricky.

Especially in "Mean Markets" like the one we're navigating right now.

So here today I'm going to show you a nifty trading trick that I use in my trading service and in my personal trading accounts – to avoid buying stocks when they are hitting emotionally charged highs.

And because of all the interest, I'm going to use Zoom as my "show you how" example… Full Story

Next Stop for Amazon (AMZN) Stock: $3,000 a Share

by

The coronavirus panic has most of the economy in a deep freeze.

Brick-and-mortar retail stores are getting hammered.

The food-supply-chain is under pressure.

Unemployment is rising.

And all the signs suggest that the U.S. economy is headed for a recession.

With the opportunity matrix changing for investors, the COVID-19 pandemic is transforming one heavyweight into an absolute juggernaut.

We're talking about Amazon.com Inc. (NASDAQ: AMZN), which has become the essential retailing icon of the pandemic.

In fact, our Michael Robinson is predicting that we'll eventually see Amazon at $3,000 a share as a result of the market.

And the stock will move even higher from there.

Here's why...

We Bust COVID Myths - and Show You How the "Real Story" Can Make You Money

by

Ever since it became clear that COVID-19 was spreading across the globe, there's been another pandemic proliferating in its wake.

This "other" pandemic isn't immediately visible to the naked eye.

It's not grabbing as many headlines.

But it's everywhere.

And it's dangerous.

Very dangerous…

I'm talking about the pandemic of misinformation, conspiracy theories, and outright lies about COVID-19.

With our world being turned upside down and scientists still searching for responses to this brand-new virus, regular folks like us are searching for answers.

And there are plenty of people in "the media" and out there in the online sphere who are only too happy to provide their half-baked guesses as "answers."

But to protect yourself, your family, and your economic wellbeing, you need to know what's really going on.

So today, let's close that Reality Gap between what half-baked pundits, self-important voices, and self-serving politicians are saying, and what we really know.

I've asked myself why I should weigh in and if I felt comfortable doing so. I answered that question by considering that – as a trained chemical engineer who was awarded the highest level of licensing – I have the credentials and the experience to sort through the scientific noise, to separate some of the signals from the noise, and to understand how these insights can be applied.

And to help make sure I'm bringing you all the "full story," I've also leaned on experts credentialed in science, medicine, risk analysis, and crisis management.

Here's what's being said about the COVID-19 pandemic. And here's what's actually true about it… Full Story

Here's what's being said about the COVID-19 pandemic. And here's what's actually true about it... Full Story

Markets Live Recap: Why Stocks Rallied to End the Week

by

The Dow jumped 260 points (1.1%) to close the week as oil extended its rebound from the negative $40 levels it touched Tuesday.

The June 2020 crude oil contracts are now trading for about $17, which is $53 higher than the -$40 number posted earlier in the week.

Despite the rebound, it's still down about 43% over the past two weeks.

Investors also weighed the possibility of Gilead Science Inc.'s (NASDAQ: GILD) new drug Remdesivir treating coronavirus patients.

It's to be seen whether it will be effective for the mass population or not…

Here's what our experts – Chris Johnson, Tom Gentile, D.R. Barton, Jr., and Shah Gilani – saw as we closed out another volatile week on Wall Street.

Read more...

[Chart] You Can Make 200% Gains on This Coming Market Move

by

It may seem like the markets are unpredictable right now.

But we've seen it all before.

While the media was busy calling the bottom or trying to figure out why stocks were rallying despite historically terrible unemployment numbers, we were giving our readers chances at making money.

Chris Johnson has a better than 83% win rate on closed trades he's recommended since March 27 with an average profit per trade of 41% in six days.

That includes the losing trades.

And if you kept that up for just 12 more days you could have turned $475 into more than $1,300.

Up the ante – and a $2,500 grubstake could have transformed into $39,000 – or more.

Now Chris is making a bold prediction set to bring you even more of these moneymaking opportunities...